Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10975388rdf:typepubmed:Citationlld:pubmed
pubmed-article:10975388lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C0022688lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C0079772lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C0521362lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C1823153lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C0332257lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C1511636lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C0439097lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C2349976lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C1552644lld:lifeskim
pubmed-article:10975388lifeskim:mentionsumls-concept:C1547348lld:lifeskim
pubmed-article:10975388pubmed:issue1-2lld:pubmed
pubmed-article:10975388pubmed:dateCreated2000-12-4lld:pubmed
pubmed-article:10975388pubmed:abstractTextGastrointestinal T cell lymphoma (TCL) is a rare subset of peripheral TCL, presenting with or without cytotoxic phenotype, a history of coeliac disease (CD) and enteropathy. However, CD is rare in Japan. Here, we describe the clinicopathological features of 18 Japanese cases. Lesions were found in the small intestine (n=13), stomach (n=3) and colon (n=2). Seven patients presented with enteropathy but none had a history of CD. Lymphomas appeared as ulceration (n=11), tumour formation (n=6), or polypoid growth (n=1). Histologically (REAL classification), neoplastic lesions were composed of intestinal type T cell lymphoma (ITCL, n=13, including one case with NK type), anaplastic large cell (ALCL, n=2), adult T cell leukaemia/lymphoma (ATLL, n=2), and lymphoblastic type (n=1). Epstein Barr virus infection was detected by EBER-1 in situ hybridization in 6 of 11 cases with ITCL but not in the other types. ALCL expressed CD30. CD56 was expressed in 3 of 11 cases of ITCL but not in other types. Among the 10 examined cases, 8 were alphabeta T cell type [CD2+, CD3+, T cell receptor (TCR)delta-1-, betaF1+], one was gammadelta T cell type [CD2+, CD3+, TCRdelta-1+, betaF1-], and the remaining case expressed natural killer (NK) cell type [CD2+, CD3-, CD56+, TCRdelta-1-, betaF1-]. Among the 8 examined cases, 3 expressed CD103 molecule, which was associated with extrathymic T cells of intraepithelial lymphocytes. All cases except ATLL expressed the cytotoxicity-associated molecule of TIA-1, and 11 of 14 TIA-1 positive cases expressed activated cytotoxic molecules of perforin, granzyme B, and/or Fas ligand. Despite the morphological, genetic and phenotypic heterogeneity, prognosis was poor, and 11 of 13 patients with small intestinal lesions died albeit appropriate treatment, but 3 of 4 patients with gastric or colonic lesions were still alive. The main cause of death was intestinal perforation. The latter might be due to the site specificity of small intestine and tumour cytotoxicity.lld:pubmed
pubmed-article:10975388pubmed:languageenglld:pubmed
pubmed-article:10975388pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:citationSubsetIMlld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10975388pubmed:statusMEDLINElld:pubmed
pubmed-article:10975388pubmed:monthSeplld:pubmed
pubmed-article:10975388pubmed:issn1042-8194lld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:KandaMMlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:KikuchiMMlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:IkedaSSlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:SugiharaMMlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:HaraokaSSlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:OhshimaKKlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:KatohAAlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:ShimazakiKKlld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:KawasakiCClld:pubmed
pubmed-article:10975388pubmed:authorpubmed-author:SuzumiyaJJlld:pubmed
pubmed-article:10975388pubmed:issnTypePrintlld:pubmed
pubmed-article:10975388pubmed:volume39lld:pubmed
pubmed-article:10975388pubmed:ownerNLMlld:pubmed
pubmed-article:10975388pubmed:authorsCompleteYlld:pubmed
pubmed-article:10975388pubmed:pagination97-111lld:pubmed
pubmed-article:10975388pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:meshHeadingpubmed-meshheading:10975388...lld:pubmed
pubmed-article:10975388pubmed:year2000lld:pubmed
pubmed-article:10975388pubmed:articleTitleGastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.lld:pubmed
pubmed-article:10975388pubmed:affiliationFirst Department of Pathology, School of Medicine, Fukuoka University, Japan.lld:pubmed
pubmed-article:10975388pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10975388pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10975388lld:pubmed